{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2016"],"condition":["colorectal cancer"],"disease":["Colorectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2667270"],"location":["China"],"study_start_month":["10"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"The prolonged adjuvant therapy with capecitabine after R0 surgery and perioperative chemotherapy for advanced colorectal cancer with only liver metastasis: a prospective, multicenter, randomized, controlled clinical study.","description":"Interventions: control group:observation;study group:Capecitabine\nPrimary outcome(s): DFS\nStudy Design: Randomized parallel controlled trial","dates":{"creation":"2016-10-15"},"accession":"2667270","cross_references":{"Chinese Clinical Trial Register":["ChiCTR-IPR-16009755"]}}